Evaluating osteopathic treatment for chronic low back pain management
Official title: Study of the Contribution of Osteopathic Treatment to Classic Medical Management in Patients With Chronic Low Back Pain
Run by Clinique Pasteur · NCT03836248 · Data updated 2026-11-12
This study tests if adding real osteopathic treatment to regular care can help people with chronic low back pain feel less pain compared to those who only get standard treatment or a fake treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 64 Years |
| Sex | All |
| Enrollment | 199 (estimated) |
| Sponsor | Clinique Pasteur Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | October 2, 2019 |
| Main results expected | June 2028 |
| Study ends | September 2028 |
| Registry record updated | March 6, 2026 |
| Trial ID | NCT03836248 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with chronic non-specific low back pain lasting more than three months.
✕Probably not a fit
Patients with specific low back pain conditions or those on certain medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of adding osteopathic treatment to standard medical management for patients suffering from chronic non-specific low back pain. It compares pain levels after three months among three groups: those receiving only classical medical treatment, those receiving classical treatment with sham osteopathic treatment, and those receiving classical treatment with actual osteopathic treatment. The aim is to determine if osteopathic treatment can significantly reduce pain compared to the other approaches.
Why it matters
Potential benefit: If successful, this study could provide a new, effective treatment option for patients with chronic low back pain.
How similar studies have gone: Other studies have shown promising results for osteopathic treatment in managing chronic pain, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with chronic non-specific low back pain: degenerative lumbalgia and low back pain unrelated to anatomical lesions that have been evolving for more than 3 months. * Patient affiliated with a social security scheme or equivalent * Patient having signed the study informed consent form. Exclusion Criteria: * Patient with specific low back pain: patient with one of the following pathologies: degenerative neurological pathology; infectious pathology; fracture vertebral lesion less than 1 year; vertebral osteosynthesis material or canal narrowing. * Patient following a treatment of the Morphinic or Neuroleptic type. * Pregnant, breastfeeding or parturient woman * Patient participating in another clinical study * Protected patient: Major under some form of guardianship ; Hospitalized without consent
Where it's running
-
Clinique Pasteur
Toulouse, France Recruiting
Study contacts
- Principal investigator: Barthélémy De Truchis de Varennes, MD — Clinique Pasteur
- Study coordinator: Barthélémy De Truchis de Varennes, MD
- Email: bdetruchis@clinique-pasteur.com
- Phone: + 33 5 62 21 35 36
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.